Safety of Switching From a VKA to an NOAC in Older Patients With Atrial Fibrillation and Frailty
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial
Circulation 2023 Aug 27;[EPub Ahead of Print], LPT Joosten, S van Doorn, PM van de Ven, BTG Köhlen, MC Nierman, HL Koek, MEW Hemels, MV Huisman, M Kruip, LM Faber, NM Wiersma, WF Buding, R Fijnheer, HJ Adriaansen, KC Roes, AW Hoes, FH Rutten, GJ GeersingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.